Search companies or stocks...
ENLVEnlivex Therapeutics Ltd.
At close · 02 Sept 2026, 07:59 pm
Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.
Enlivex Therapeutics Ltd. operates as a clinical-stage macrophage reprogramming immunotherapy company. It is developing Allocetra, a cell-based therapy to treat organ…
Current stock price of Enlivex Therapeutics Ltd. (ENLV) stock is $1.280. The stock price is +0.00% higher in the session. The intraday range can be seen from this page. Volume of Enlivex Therapeutics Ltd. (ENLV) stock is 225.54K.
Last updated at 02 Sept 2026, 07:59 pm.
The stock price of Enlivex Therapeutics Ltd. (ENLV) can change with earnings, company news, and overall market sentiment. Enlivex Therapeutics Ltd. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.
Whether Enlivex Therapeutics Ltd. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for ENLV on this page is 0.00. EPS on this page is 404.50. Compare those figures with peers and growth expectations before deciding if the current Enlivex Therapeutics Ltd. price is justified.
Historical performance for Enlivex Therapeutics Ltd. (ENLV) is shown on the price chart on this page. Review multi-period moves alongside volume to see how ENLV reacted to past earnings and market events.
Buying Enlivex Therapeutics Ltd. (ENLV) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.
